Quick Answer
MoonLake Immunotherapeutics reported Long-Term Debt of $74.10 million for fiscal year 2025.
MoonLake Immunotherapeutics Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $74.10M | — |
| 2024 | $0.00 | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $73.74M | — | +0.5% |
| June 30, 2025 | $73.38M | — | +0.5% |
| March 31, 2025 | $73.02M | — | — |
| December 31, 2024 | $0.00 | — | — |
- The most recent figure is from MoonLake Immunotherapeutics’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: